EPCAM and breast cancer: A live/dead cell assay was performed to determine the MCF-7 cellular binding/uptake of EINPs (Figure 6) to verify that the EINPs anti-EpCAM functionalized nanotheranostic carriers accurately targeted the MCF-7 breast-cancer cells.